Story perspectives

Trump DOJ Declines FDA Defense as Court Restores Mifepristone Access

5/19/2026

Summary

Story summary

President Donald Trump's Justice Department refused to file a brief defending the FDA in Supreme Court mifepristone case.
The Supreme Court reinstated nationwide telemedicine and mail delivery of mifepristone while the lawsuit proceeds in lower courts.
Abortion rates have risen slightly since the 2022 overturn of Roe v. Wade because the medication is more accessible.
Analysts say the administration’s silence reflects Republican political pressure ahead of the 2026 midterms.

1 of 1

Story summary

President Donald Trump's Justice Department refused to file a brief defending the FDA in Supreme Court mifepristone case.
The Supreme Court reinstated nationwide telemedicine and mail delivery of mifepristone while the lawsuit proceeds in lower courts.
Abortion rates have risen slightly since the 2022 overturn of Roe v. Wade because the medication is more accessible.
Analysts say the administration’s silence reflects Republican political pressure ahead of the 2026 midterms.